Expression Systems for the Production of Recombinant Pharmaceuticals

Author： Sodoyer R.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.18, Iss.1, 2004-01, pp. : 51-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Costs and Benefits of Pharmaceuticals: The Value Equation for Older Americans

By Levy Richard  

Care Management Journals, Vol. 3, Iss. 3, 2002-01 ,pp. : 135-143

Springer Publishing Company

Access to resources Recommend Favorite

Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-12 ,pp. : 60-68

Bentham Science Publishers

Access to resources Recommend Favorite

Recombinant Factor VIIa

By Dunn C.J.   Spencer C.M.  

BioDrugs, Vol. 12, Iss. 1, 1999-07 ,pp. : 71-77

Adis International

Access to resources Recommend Favorite

Understanding and Applying Regulatory Guidance on the Nonclinical Development of Biotechnology-Derived Pharmaceuticals

By Snodin David J.  

BioDrugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 25-52

Adis International

Access to resources Recommend Favorite

Criteria for the Design and Biological Characterization of Radiolabeled Peptide-Based Pharmaceuticals

By Ettore Benedetti   Giancarlo Morelli   Antonella Accardo   Rosalba Mansi   Diego Tesauro   Luigi Aloj  

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 279-295

Adis International

Access to resources Recommend Favorite